Dengue Literature Review

Singapore

4 min read

Singapore

Overview

Singapore is a city-state in Southeast Asia with year-round dengue transmission due to the tropical climate and the presence of Aedes aegypti and Aedes albopictus vectors. Despite strong vector control programmes, Singapore experiences periodic dengue outbreaks. Dengue is the ninth most common cause of hospitalization in Singapore (8,284 hospitalizations in 2004; 3,913 in 2002). The incidence is approximately 1–4 cases per 10,000 population per year in non-outbreak periods.

Key Points from Literature

2005 Outbreak (October–November)

  • A dengue outbreak occurred at the National University Hospital (NUH) during October–November 2005 and was the setting for the Seet2007 post-dengue fatigue cohort.
  • Serotyping of 27/127 hospitalized patients identified DEN-1 as the dominant circulating serotype (20/27, 74%), with DEN-3 in 6 patients (22%) and DEN-4 in 1 (4%) (see Seet2007 - Post-Infectious Fatigue Syndrome in Dengue).
  • The outbreak patient profile: mean age 36 years; 55.9% male; 75.6% Chinese, 17.3% Malay, 4.7% Indian ethnicity.
  • Clinical profile: 80.3% dengue fever, 19.7% dengue haemorrhagic fever; no dengue shock syndrome reported in this cohort. Common acute symptoms: fever (93.7%), poor appetite (89%), fatigue (80.3%), headache (74.8%), nausea and chills (69.3% each), muscle pain (62.2%).

Post-Dengue Outcomes

  • 24.4% of hospitalized patients had significant post-infectious fatigue at 2 months after discharge, measured by validated Fatigue Questionnaire (see Post-Dengue Syndrome).
  • Predictors of post-infectious fatigue: older age, female sex, presence of chills, absence of rashes — not dengue severity.
  • This is the first prospective systematic study of post-dengue sequelae outside Cuba (cf. Latin America § Cuba — DENV-4 2006 epidemic data from Garcia2009/Garcia2010).

Epidemic History and Vector Control

  • Major outbreak years: 1992, 1998, 2004. The 2004 outbreak was the largest on record: 9,459 cases in a population of ~4 million.
  • Singapore’s vector control program is one of the most intensive globally; the country has used source reduction, biological control, and more recently Wolbachia-based vector suppression trials (referenced in Guzman2016 - Dengue Infection; see Wolbachia and Aedes aegypti).

SLE-Dengue Diagnostic Confusion

  • Santosa2012 - Delayed SLE Diagnosis Dengue Serology (NUHS + Singapore General Hospital) documents delayed SLE diagnosis in a 20-year-old Malay male caused by false-positive dengue IgM: polyclonal B-cell activation in SLE generates ~120 autoantibodies including low-affinity IgM species that cross-bind dengue IgM test kit antigens. The patient was initially treated for probable dengue fever; 3 weeks later, re-presentation with seizures, ANA 1:320, anti-dsDNA, and hypocomplementemia led to the correct SLE diagnosis. False-positivity was confirmed by absence of IgM seroconversion — true dengue IgM persists 8–12 weeks.
  • Kit-specific false-positive rate (Panbio Dengue IgM/IgG immunochromatography, unpublished local data): RF-positive patients 3/20 (15%) for dengue IgM, 0/20 for dengue IgG; ANA-positive patients 0/10 for either — no cross-reactivity detected.
  • Practical implication: In endemic Singapore, the high pre-test probability of dengue means false-positive serology can delay or preempt a rheumatological workup. For patients with known or suspected autoantibodies, NS1 antigen (92% sensitivity, 100% specificity within 9 days) or RT-PCR (within 5 days) are recommended as primary confirmatory tests; dengue IgM alone is unreliable.
  • The hazard is bidirectional: immunosuppressive therapy can also cause false-negative dengue serology in patients with established SLE who develop true dengue, complicating the lupus-flare vs. infection distinction.

Dengue-Associated Retinal Vasculitis

  • Palacios2016 - Autoimmunity in Dengue Literature Review cites Chang et al. (2007) reporting retinal vasculitis in young women in Singapore following dengue virus infection. The proposed mechanism is immune-complex deposition consequent to antibody production triggered by dengue infection — adding an ophthalmological dimension to the dengue-autoimmunity spectrum (see Autoimmunity in Dengue).

Sources

Graph View

Backlinks